144550-76-5 Usage
General Description
Methyl2-Amino-4-Iodobenzoate belongs to the family of chemical compounds known as amino-4-iodobenzoates creating through a series of synthetic processes. It's an organic compound with the presence of an amino group (-NH2) and an iodine atom along with a methyl ester (-CO2CH3) attached to the benzene ring. The presence of these functional groups suggests its role as a chemical intermediate in pharmaceuticals and other chemical synthesis processes. Currently, there's limited information on the specific properties of this compound, thus research into its physical and chemical properties, toxicology, and potential uses is crucial.
Check Digit Verification of cas no
The CAS Registry Mumber 144550-76-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,5,5 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 144550-76:
(8*1)+(7*4)+(6*4)+(5*5)+(4*5)+(3*0)+(2*7)+(1*6)=125
125 % 10 = 5
So 144550-76-5 is a valid CAS Registry Number.
144550-76-5Relevant articles and documents
PROCESS FOR PREPARING A NOVEL CRYSTALLINE FORM OF IODOSULFURON-METHYL-SODIUM AND USE OF THE SAME
-
Paragraph 0058, (2017/05/19)
A crystalline form of iodosulfuron-methyl-sodium of formula (I), the crystal preparation process, the analyses of the crystal through various analytical methods and using the crystal to prepare stable agrochemical formulation. The invention also describes the use of various solvents towards the crystalline form preparation conditions.
5, 7-DIHYDRO- 6H-PYRIMIDO [ 5, 4-D] [ 1 ] BENZAZEPIN-6-THIONES AS PLK INHIBITORS
-
Page/Page column 58-59, (2010/06/20)
This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, and R6 are as described in the specification. The compounds are inhibitors of PLK and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
SULFONAMIDE COMPOUNDS
-
Page/Page column 51, (2010/10/20)
Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.